Search Within

Kaida Wu

Formats
  1. Meeting Abstract (16)
  2. Journal Article (13)
Groups
  1. Cell Biology Program Faculty (29)
  2. Sloan Kettering Institute Faculty (29)
  3. Radiochemistry and Imaging Sciences Service (5)
  4. Radiology, Department of (5)
  5. Molecular Pharmacology and Chemistry Program Faculty (4)
  6. Department of Medicine (2)

More Groups

People
  1. Malcolm Moore (29)
  2. Vladimir Ponomarev (5)
  3. Samuel Danishefsky (4)
  4. Eunice Wang (3)
  5. Jae-Hung Shieh (3)
  6. Lisa Orme (3)

More People

Years
  1. 2007 (1)
  2. 2006 (3)
  3. 2005 (10)
  4. 2004 (5)
  5. 2003 (4)
  6. 2002 (3)

More Years

Publications
  1. Blood (16)
  2. Cancer Research (6)
  3. Cancer Immunology, Immunotherapy (1)
  4. Cloning and Stem Cells (1)
  5. Drugs of the Future (1)
  6. Journal of the American Chemical Society (1)

More Publications

Publishers
  1. American Society of Hematology (16)
  2. American Association for Cancer Research (6)
  3. AlphaMed Press (1)
  4. American Chemical Society (1)
  5. Humana Press Inc (1)
  6. Mary Ann Liebert, Inc (1)

More Publishers

Results (29)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Antibody targeting of the insulin-like growth factor I receptor enhances the anti-tumor response of multiple myeloma to chemotherapy through inhibition of tumor proliferation and angiogenesis
    Journal Article

    Wu, K. D.; Zhou, L.; Burtrum, D.; Ludwig, D. L.; Moore, M. A. S.
    Cancer Immunology, Immunotherapy (2007)

    Fulltext@MSK | Save
  • A novel orally active small molecule potently induces G1 arrest in primary myeloma cells and prevents tumor growth by specific inhibition of Cdk4/6
    Meeting Abstract

    Baughn, L. B.; Di Liberto, M.; Wu, K.; Toogood, P.; Louie, T.; Gottschalk, R.; Niesvizky, R.; Cho, H. J.; Ely, S.; Moore, M. A. S.; more...
    Blood (2006)

    Fulltext@MSK | Save
  • Telomere-driven karyotypic complexity concurs with p16INK4a inactivation in TP53-competent immortal endothelial cells
    Journal Article

    Wen, V. W.; Wu, K.; Baksh, S.; Hinshelwood, R. A.; Lock, R. B.; Clark, S. J.; Moore, M. A. S.; Mackenzie, K. L.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • A novel orally active small molecule potently induces G1 arrest in primary myeloma cells and prevents tumor growth by specific inhibition of cyclin-dependent kinase 4/6
    Journal Article

    Baughn, L. B.; Di Liberto, M.; Wu, K.; Toogood, P. L.; Louie, T.; Gottschalk, R.; Niesvizky, R.; Cho, H.; Ely, S.; Moore, M. A. S.; more...
    Cancer Research (2006)

    Fulltext@MSK | Save
  • A humanized insulin-like growth factor I receptor antibody inhibits multiple myeloma cell growth in vivo through anti-angiogenesis
    Meeting Abstract

    Wu, K.; Zhou, L.; Zhang, K.; Burtrum, D.; Ludwig, D. L.; Moore, M. A. S.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • Investigation of the anti-tumor effect of synthetic epothilone analogs in human myeloma model in vitro and in vivo
    Meeting Abstract

    Wu, K.; Luong, R.; Cho, Y. S.; Katz, J.; La Perle, K. M. D.; Ponomarev, V.; Danishefsky, S. J.; Moore, M. A. S.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • The telomerase template antagonist GRN163L reduces tumor volume in a multiple myeloma xenograft model
    Meeting Abstract

    Ertem, S. A.; Wang, E.; Wu, K.; Ponomarev, V.; Tressler, R.; Chin, A. C.; Moore, M. A. S.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • The telomerase template antagonist GRN163L reduces tumor volume in a human ovarian carcinoma xenograft model
    Meeting Abstract

    Ertem, S. A.; Liedtke, M.; Chung, K. Y.; Wu, K.; Ponomarev, V.; Tressler, R.; Chin, A. C.; Moore, M. A. S.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • The telomerase template antagonist GRN163L in combination with chemotherapeutics reduces tumor volume in multiple myeloma xenograft models
    Meeting Abstract

    Ertem, S. A.; Wu, K. D.; Ponomarev, V.; Chin, A. C.; Moore, M. A. S.
    Blood (2005)

    Fulltext@MSK | Save
  • Aberrant autocrine and paracrine CD40L signaling promotes primary myeloma cell survival and attenuates bortezomib-induced apoptosis
    Meeting Abstract

    Chen-Kiang, S.; Ely, S.; Di Liberto, M.; Wu, K. D.; Shaughnessy, J.; Moore, M.; Niesvizky, R.; Hatada, E.
    Blood (2005)

    Fulltext@MSK | Save